Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer|September 15, 1993
Elevated serum CA 125 secondary to tuberculous peritonitisS A Candocia, G Y Locker
Cancer Treatment Reports|May 1, 1979
Experimental animal models of adriamycin cardiotoxicityJ H Doroshow, G Y Locker, C E Myers
The Journal of Clinical Investigation|January 1, 1980
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicinJ H Doroshow, G Y Locker, C E Myers
Research Communications in Chemical Pathology and Pharmacology|November 1, 1979
The effect of doxorubicin on hepatic and cardiac glutathioneJ H Doroshow, G Y Locker, J Baldinger, et al.
The Journal of Clinical Investigation|October 1, 1981
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteineJ H Doroshow, G Y Locker, I Ifrim, et al.
Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.
Cancer|November 15, 1981
Ocular irritation from high-dose methotrexate therapy: pharmacokinetics of drug in the tear filmJ H Doroshow, G Y Locker, D E Gaasterland, et al.
The Lancet. Oncology|August 5, 2006
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial, A Buzdar, A Howell, et al.
Cancer Treatment Reports|February 1, 1979
Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycinR F Ozols, G Y Locker, J H Doroshow, et al.
Cancer Treatment Reports|June 1, 1987
Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council TrialG Y Locker, J Khandekar, S Krauss, et al.
Pageof 2